GILD
Price
$112.46
Change
+$2.00 (+1.81%)
Updated
Jun 6 closing price
Capitalization
90.79B
57 days until earnings call
PFE
Price
$23.35
Change
+$0.23 (+0.99%)
Updated
Jun 6 closing price
Capitalization
157.14B
57 days until earnings call
Interact to see
Advertisement

GILD vs PFE

Header iconGILD vs PFE Comparison
Open Charts GILD vs PFEBanner chart's image
Gilead Sciences
Price$112.46
Change+$2.00 (+1.81%)
Volume$5.26M
Capitalization90.79B
Pfizer
Price$23.35
Change+$0.23 (+0.99%)
Volume$30.43M
Capitalization157.14B
GILD vs PFE Comparison Chart
Loading...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GILD vs. PFE commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GILD is a Buy and PFE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (GILD: $108.44 vs. PFE: $23.18)
Brand notoriety: GILD and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GILD: 51% vs. PFE: 73%
Market capitalization -- GILD: $90.79B vs. PFE: $157.14B
GILD [@Pharmaceuticals: Major] is valued at $90.79B. PFE’s [@Pharmaceuticals: Major] market capitalization is $157.14B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GILD’s FA Score shows that 2 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • GILD’s FA Score: 2 green, 3 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, GILD is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GILD’s TA Score shows that 6 TA indicator(s) are bullish while PFE’s TA Score has 2 bullish TA indicator(s).

  • GILD’s TA Score: 6 bullish, 3 bearish.
  • PFE’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, GILD is a better buy in the short-term than PFE.

Price Growth

GILD (@Pharmaceuticals: Major) experienced а +0.67% price change this week, while PFE (@Pharmaceuticals: Major) price change was +0.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.22%. For the same industry, the average monthly price growth was +3.78%, and the average quarterly price growth was +3.49%.

Reported Earning Dates

GILD is expected to report earnings on Aug 05, 2025.

PFE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.22% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PFE($157B) has a higher market cap than GILD($90.8B). PFE has higher P/E ratio than GILD: PFE (74.92) vs GILD (16.20). GILD YTD gains are higher at: 18.221 vs. PFE (-9.488). GILD has higher annual earnings (EBITDA): 10.5B vs. PFE (9.56B). PFE has more cash in the bank: 12.7B vs. GILD (7.26B). GILD has less debt than PFE: GILD (25B) vs PFE (70.8B). PFE has higher revenues than GILD: PFE (58.5B) vs GILD (27.1B).
GILDPFEGILD / PFE
Capitalization90.8B157B58%
EBITDA10.5B9.56B110%
Gain YTD18.221-9.488-192%
P/E Ratio16.2074.9222%
Revenue27.1B58.5B46%
Total Cash7.26B12.7B57%
Total Debt25B70.8B35%
FUNDAMENTALS RATINGS
GILD vs PFE: Fundamental Ratings
GILD
PFE
OUTLOOK RATING
1..100
814
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
19100
SMR RATING
1..100
8872
PRICE GROWTH RATING
1..100
4258
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (3) in the Pharmaceuticals Major industry is in the same range as GILD (17) in the Biotechnology industry. This means that PFE’s stock grew similarly to GILD’s over the last 12 months.

GILD's Profit vs Risk Rating (19) in the Biotechnology industry is significantly better than the same rating for PFE (100) in the Pharmaceuticals Major industry. This means that GILD’s stock grew significantly faster than PFE’s over the last 12 months.

PFE's SMR Rating (72) in the Pharmaceuticals Major industry is in the same range as GILD (88) in the Biotechnology industry. This means that PFE’s stock grew similarly to GILD’s over the last 12 months.

GILD's Price Growth Rating (42) in the Biotechnology industry is in the same range as PFE (58) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to PFE’s over the last 12 months.

PFE's P/E Growth Rating (96) in the Pharmaceuticals Major industry is in the same range as GILD (100) in the Biotechnology industry. This means that PFE’s stock grew similarly to GILD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GILDPFE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 13 days ago
53%
Bearish Trend 13 days ago
53%
Momentum
ODDS (%)
Bullish Trend 13 days ago
51%
Bullish Trend 13 days ago
51%
MACD
ODDS (%)
Bullish Trend 13 days ago
63%
N/A
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
49%
Bearish Trend 13 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
59%
Bullish Trend 13 days ago
49%
Advances
ODDS (%)
Bullish Trend 21 days ago
57%
Bullish Trend 14 days ago
56%
Declines
ODDS (%)
Bearish Trend 19 days ago
51%
Bearish Trend 27 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
53%
Bearish Trend 13 days ago
64%
Aroon
ODDS (%)
Bullish Trend 13 days ago
57%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with AMGN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
-0.60%
AMGN - GILD
46%
Loosely correlated
-0.38%
BMY - GILD
46%
Loosely correlated
+0.17%
PFE - GILD
43%
Loosely correlated
-1.82%
JNJ - GILD
42%
Loosely correlated
-0.54%
ABBV - GILD
41%
Loosely correlated
-1.42%
More

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with AMGN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
-1.82%
AMGN - PFE
57%
Loosely correlated
-0.38%
GSK - PFE
55%
Loosely correlated
-0.66%
NVS - PFE
52%
Loosely correlated
-1.18%
ABBV - PFE
51%
Loosely correlated
-1.42%
JNJ - PFE
51%
Loosely correlated
-0.54%
More